Enhanced aggregability of red blood cells of beta-thalassemia major patients

S. Chen, A. Eldor, G. Barshtein, S. Zhang, A. Goldfarb, E. Rachmilewitz and S. Yedgar Department of Biochemistry, Hebrew University-Hadassah Medical School, Hadassah University Hospital, Jerusalem, Israel. beta-Thalassemia major (TM), a congenital hemoglobinopathy, is associated with hemodynamic dis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 1996-06, Vol.270 (6), p.H1951-H1956
Hauptverfasser: Chen, S, Eldor, A, Barshtein, G, Zhang, S, Goldfarb, A, Rachmilewitz, E, Yedgar, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:S. Chen, A. Eldor, G. Barshtein, S. Zhang, A. Goldfarb, E. Rachmilewitz and S. Yedgar Department of Biochemistry, Hebrew University-Hadassah Medical School, Hadassah University Hospital, Jerusalem, Israel. beta-Thalassemia major (TM), a congenital hemoglobinopathy, is associated with hemodynamic disorders and with structural red blood cell (RBC) anomalies that may indicate impairment of RBC rheological properties. To gain insight into the possible contribution of RBC to the hemodynamic disorders, we studied RBC aggregability, which plays a central role in blood flow, particularly in the microcirculation. RBC aggregate size distribution and morphology of TM RBC were determined using a novel system for image analysis of blood cells in a flow chamber. It was found that the aggregability of RBC of TM patients is markedly enhanced. These cells form large clusters, as opposed to normal rouleaux, and higher shear stress is required to disperse them. The aggregate size of TM RBC is reduced to the normal range after the patients have received a blood transfusion. This study suggests that the hemodynamic disorders observed in TM may be linked to the enhanced RBC aggregability and that improvement of RBC rheological properties may be considered in the treatment of thalassemia.
ISSN:0363-6135
0002-9513
1522-1539
DOI:10.1152/ajpheart.1996.270.6.h1951